Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.
Reinhardt
D
D
Diekamp
S
S
Langebrake
C
C
Ritter
J
J
Stary
J
J
Dworzak
M
M
Schrauder
A
A
Zimmermann
M
M
Fleischhack
G
G
Ludwig
W-D
WD
Harbott
J
J
Creutzig
U
U
D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007223:Infant; D007947:Leukemia, Megakaryoblastic, Acute / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D012074:Remission Induction / Q000379:methods; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
D003561:Cytarabine; D005047:Etoposide; D015255:Idarubicin